Header Logo

Ninfa Maria Candela MD

TitleAssistant Professor
InstitutionUMass Chan Medical School
DepartmentPediatrics
AddressUMass Chan Medical School
55 Lake Avenue North
Worcester MA 01655
Phone508-856-3497
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentPediatrics
    DivisionPediatric Gastroenterology


    Collapse Biography 
    Collapse education and training
    St. Joseph's College Brooklyn, Brooklyn, NY, United StatesBSBiology
    St. George's University School of Medicine, Bay Shore, , GrenadaMD

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cleveland NK, Ghosh S, Kathe N, Umashankar K, Mirchandani K, Hait A, Paul R, Candela N, Fan T, Rubin DT. Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD study. J Manag Care Spec Pharm. 2024 Nov; 30(11):1276-1287. PMID: 39471266.
      Citations:    
    2. Krugliak Cleveland N, Candela N, Carter JA, Kuharic M, Qian J, Tang Z, Turpin R, Rubin DT. Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis. Crohns Colitis 360. 2024 Oct; 6(4):otae061. PMID: 39502268.
      Citations:    
    3. Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflamm Bowel Dis. 2024 10 03; 30(10):1776-1787. PMID: 37921344.
      Citations:    Fields:    
    4. Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterol. 2024 Sep 17; 24(1):314. PMID: 39289603.
      Citations:    
    5. Chiorean M, Jiang J, Candela N, Chen G, Romdhani H, Latremouille-Viau D, Shi S, Bungay R, Guerin A, Fan T. Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United States. Curr Med Res Opin. 2024 05; 40(5):877-885. PMID: 38586979.
      Citations:    
    6. Ghosh S, Kathe N, Umashankar K, Mirchandani K, Hait A, Paul R, Candela N, Fan T. Dose Escalation of Biologics in Biologic-Na?ve Patients With Ulcerative Colitis: Outcomes From the ODESSA-UC Study. Crohns Colitis 360. 2023 Oct; 5(4):otad061. PMID: 38028955.
      Citations:    
    7. Sandborn WJ, Chen J, Kisfalvi K, Loftus EV, D'Haens G, Candela N, Lasch K, Wolf DC, Uddin SM, Danese S. Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies. Crohns Colitis 360. 2023 Jul; 5(3):otad034. PMID: 37636008.
      Citations:    
    8. Vu M, Ghosh S, Umashankar K, Weber L, Landis C, Candela N, Chastek B. Comparison of surgery rates in biologic-na?ve patients with Crohn's disease treated with vedolizumab or ustekinumab: findings from SOJOURN. BMC Gastroenterol. 2023 Mar 25; 23(1):87. PMID: 36966279.
      Citations:    Fields:    Translation:Humans
    9. Kaplan JL, Liu C, King EC, Bass JA, Patel AS, Tung J, Chen S, Lissoos T, Candela N, Saeed S, Colletti RB. Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort. J Pediatr Gastroenterol Nutr. 2023 05 01; 76(5):566-575. PMID: 36804501.
      Citations: 3     Fields:    Translation:Humans
    10. Jairath V, Cohen RD, Loftus EV, Candela N, Lasch K, Schultz BG. Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis. BMC Gastroenterol. 2022 Dec 06; 22(1):501. PMID: 36474165.
      Citations: 1     Fields:    
    11. Ungaro RC, Chou B, Mo J, Ursos L, Twardowski R, Candela N, Colombel JF. Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA. J Crohns Colitis. 2022 Sep 08; 16(9):1405-1414. PMID: 35396598.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    12. Kuharic M, Krugliak Cleveland N, Candela N, Carter J, Qian J, Rusibamayila N, Turpin R, Rubin D. P042 Early Versus Later Use of Vedolizumab In IBD: Patient Characteristics And Treatment Patterns In The Real World (RALEE). Am J Gastroenterol. 2021 Dec 01; 116(Suppl 1):S11. PMID: 37461960.
      Citations:    Fields:    
    13. Siegel CA, Siegel LS, Dubinsky MC, Targan S, Braun J, Landers C, Bilsborough J, Princen F, Lasch K, Candela N, McGovern DPB, Dervieux T. Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's Disease. Crohns Colitis 360. 2021 Oct; 3(4):otab074. PMID: 36777269.
      Citations:    
    14. Creo AL, Candela N, Lee MM, Feldman PM. An Unusual Manifestation of Celiac Disease in an Adolescent With Down Syndrome and Graves Disease. J Pediatr Gastroenterol Nutr. 2017 07; 65(1):e20-e22. PMID: 28644364.
      Citations: 1     Fields:    Translation:Humans
    15. Nwosu BU, Maranda L, Candela N. Correction: Vitamin D status in pediatric irritable bowel syndrome. PLoS One. 2017; 12(3):e0173779. PMID: 28278247.
      Citations:    Fields:    
    16. Nwosu BU, Maranda L, Candela N. Vitamin D status in pediatric irritable bowel syndrome. PLoS One. 2017; 12(2):e0172183. PMID: 28192499.
      Citations: 17     Fields:    Translation:Humans
    17. Setty-Shah N, Maranda L, Candela N, Fong J, Dahod I, Rogol AD, Nwosu BU. Lactose intolerance: lack of evidence for short stature or vitamin D deficiency in prepubertal children. PLoS One. 2013; 8(10):e78653. PMID: 24205288.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    18. Frank GR, Fox J, Candela N, Jovanovic Z, Bochukova E, Levine J, Papenhausen PR, O'Rahilly S, Farooqi IS. Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency. Mol Genet Metab. 2013 Sep-Oct; 110(1-2):191-4. PMID: 23800642.
      Citations: 18     Fields:    Translation:Humans
    19. Fuchs Y, Candela N, Sung C, Weinstein T, Levine J. Splenic pseudoaneurysm in a child with hereditary pancreatitis. J Pediatr Gastroenterol Nutr. 2010 Jun; 50(6):686-7. PMID: 20386320.
      Citations: 1     Fields:    Translation:Humans
    Candela's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (74)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _